Soligenix, Inc. (NASDAQ: SNGX) Developing Treatments for Multiple Cancers, Vaccine Candidates (Ebola, Sudan, & Marburg)
Developing Treatments for Multiple Cancers; Vaccine Candidates (Ebola, Sudan, and Marburg) Plus a Novel Heat Stable COVID-19 & Ricin Toxin Vaccines:Soligenix, Inc. (NASDAQ: SNGX) Focus on Commercializing Products for Cancers and Rare Diseases. Successful Phase 3 Trial for Novel Photodynamic Therapy for Treatment of Cutaneous T-Cell Lymphoma (CTCL). Vaccine Programs Incorporate Proprietary Heat Stabilization Platform […]








